Disease Control Achieved Using Atezolizumab + Bevacizumab in a Patient With Sarcomatoid Hepatocellular Carcinoma (SHCC), a Rare Variant Excluded From the IMbrave150 Trial

por Fencer, Maria G., Davis, Catherine H., Liu, Jieqi, Galan, Mark A., Spencer, Kristen R.
Publicado 2022